Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-040548
Filing Date
2017-06-16
Accepted
2017-06-16 16:45:05
Documents
1
Period of Report
2017-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3987
  Complete submission text file 0001209191-17-040548.txt   5344
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Garland J. Scott (Reporting) CIK: 0001533228 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 17916607